Profil
Christopher Evangelista worked as a Sales Director at Verix, Inc., Director-Business Development at Synergistix, Inc., and as a Principal at AstraZeneca PLC, J.P.
Morgan & Co., Inc. (Old), and rEVO Biologics, Inc. He obtained an undergraduate degree from Moravian College.
Anciens postes connus de Christopher Evangelista
| Sociétés | Poste | Fin |
|---|---|---|
Verix, Inc.
Verix, Inc. Packaged SoftwareTechnology Services Provides an AI based commercial optimization platform for pharmaceutical companies | Sales & Marketing | - |
| REVO BIOLOGICS INC | Corporate Officer/Principal | - |
J.P. Morgan & Co., Inc. (Old)
J.P. Morgan & Co., Inc. (Old) Regional BanksFinance Provides commercial banking and investment advisory services | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Synergistix, Inc.
Synergistix, Inc. Information Technology ServicesTechnology Services Provides customer management tools | Corporate Officer/Principal | - |
Formation de Christopher Evangelista
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
J.P. Morgan & Co., Inc. (Old)
J.P. Morgan & Co., Inc. (Old) Regional BanksFinance Provides commercial banking and investment advisory services | Finance |
Moravian College
Moravian College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verix, Inc.
Verix, Inc. Packaged SoftwareTechnology Services Provides an AI based commercial optimization platform for pharmaceutical companies | Technology Services |
Synergistix, Inc.
Synergistix, Inc. Information Technology ServicesTechnology Services Provides customer management tools | Technology Services |
rEVO Biologics, Inc.
rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
















